Due to the COVID-19 pandemic, the global Aspergillosis Drugs market size is estimated to be worth US$ 4049.4 million in 2022 and is forecast to a readjusted size of US$ 5174.2 million by 2030 with a CAGR of 3.5% during the forecast period 2023-2030. Fully considering the economic change by this health crisis, the Europe Aspergillosis Drugs market is estimated at US$ million in 2023, while the United States and China are forecast to reach US$ million and US$ million by 2030, respectively. The proportion of the United States is % in 2023, while Chinese percentage is %, and it is predicted that China market share will reach % in 2030, trailing a CAGR of % through the analysis period. As for the Europe Aspergillosis Drugs landscape, Germany is projected to reach US$ million by 2030. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Caspofungin Acetate accounting for % of the Aspergillosis Drugs global market in 2022, is projected to value US$ million by 2030, growing at a revised % CAGR from 2023 to 2030. While Invasive Aspergillosis segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2030.

The global major manufacturers of Aspergillosis Drugs include Merck, Pfizer Deutschland GmbH, GSK, Janssen Pharmaceutica, Astellas, Basilea Pharmaceutica, Cardinal Health, Taj Pharma and SRS Pharmaceuticals Pvt. Ltd, etc. In terms of revenue, the global 3 largest players have a % market share of Aspergillosis Drugs in 2022.

 

This report focuses on Aspergillosis Drugs volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Aspergillosis Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

 

Global Aspergillosis Drugs Market: Segment Analysis

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2018 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

 

Segment by Type

 

  • Caspofungin Acetate
  • Itraconazole Capsules
  • Voriconazole Tablets

 

Segment by Application

 

  • Invasive Aspergillosis
  • Allergic Aspergillosis
  • Allergic Bronchopulmonary Aspergillosis

 

By Region

 

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Philippines
  • Vietnam
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE

 

By Company

 

  • Merck
  • Pfizer Deutschland GmbH
  • GSK
  • Janssen Pharmaceutica
  • Astellas
  • Basilea Pharmaceutica
  • Cardinal Health
  • Taj Pharma
  • SRS Pharmaceuticals Pvt. Ltd
  • United Biotech
  • Lepu Pharmaceuticals
  • Tianjin Lisheng Pharmaceutical
  • Honz Pharmaceutical
  • Huasun Pharmaceutical
  • Luoxin Biotechnology
  • Natco Pharma


Table of content

1 Aspergillosis Drugs Market Overview
1.1 Product Overview and Scope of Aspergillosis Drugs
1.2 Aspergillosis Drugs Segment by Type
1.2.1 Global Aspergillosis Drugs Sales Growth Rate Comparison by Type (2023-2030)
1.2.2 Caspofungin Acetate
1.2.3 Itraconazole Capsules
1.2.4 Voriconazole Tablets
1.3 Aspergillosis Drugs Segment by Application
1.3.1 Global Aspergillosis Drugs Sales Comparison by Application: (2023-2030)
1.3.2 Invasive Aspergillosis
1.3.3 Allergic Aspergillosis
1.3.4 Allergic Bronchopulmonary Aspergillosis
1.4 Global Aspergillosis Drugs Market Size Estimates and Forecasts
1.4.1 Global Aspergillosis Drugs Revenue 2018-2030
1.4.2 Global Aspergillosis Drugs Sales 2018-2030
1.4.3 Aspergillosis Drugs Market Size by Region: 2018 Versus 2022 Versus 2030
2 Aspergillosis Drugs Market Competition by Manufacturers
2.1 Global Aspergillosis Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Aspergillosis Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Aspergillosis Drugs Average Price by Manufacturers (2018-2023)
2.4 Manufacturers Aspergillosis Drugs Manufacturing Sites, Area Served, Product Type
2.5 Aspergillosis Drugs Market Competitive Situation and Trends
2.5.1 Aspergillosis Drugs Market Concentration Rate


CONTACT US:
276 5th Avenue, New York, NY 10001, United States
International: +1(646)-781-7170 / +91 8087042414